Carcinoma mammario metastatico HR+/HER2-: everolimus nelle pazienti con malattia indolente, dopo progressione ad una prima linea ormonale
Clinical Brief Anno II, N. 3, Agosto 2016
ISSN 2499-7706
HPS srl
Milano: Piazza Duca d’Aosta, 12 – 20124 – Tel +39 02 2772 991 (Sede legale)
Roma: Viale dell’Arte, 25 – 00144
PEC hps.srl@legalmail.it | P.IVA 07106000966 | REA MI – 1935962 | Capitale Sociale: €20.000 i.v.
Cookie | Durata | Descrizione |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |